NICE guidance on obesity management (TA875 and NG218) recommends a multicomponent approach including dietary modification, physical activity, and behavioural strategies, with pharmacotherapy reserved for appropriate patients who have not achieved adequate weight loss through lifestyle measures alone
Well arrange a check-in with a provider to review your plan, address any concerns, and, if appropriate, place a reorder for your medication
Practical concerns: alcohol can amplify nausea, hypoglycemia risk (especially with diabetes medications), and dehydration
In clinical trials, for people with type 2 diabetes, people using Ozempic achieved weight loss ranging from around 7% to more than 12% of their initial body weight, on average